Eldridge Investment Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $817K | Sell |
6,793
-1,074
| -14% | -$124K | 0.18% | 78 |
|
|
2025
Q4 | $828K | Sell |
7,867
-238
| -3% | -$22.3K | 0.18% | 81 |
|
|
2025
Q3 | $680K | Buy |
8,105
+4
| +0% | +$329 | 0.15% | 90 |
|
|
2025
Q2 | $641K | Sell |
8,101
-4
| -0% | -$318 | 0.13% | 95 |
|
|
2025
Q1 | $727K | Buy |
8,105
+6
| +0.1% | +$560 | 0.17% | 92 |
|
|
2024
Q4 | $806K | Buy |
8,099
+6
| +0.1% | +$619 | 0.19% | 88 |
|
|
2024
Q3 | $919K | Sell |
8,093
-156
| -2% | -$18.5K | 0.22% | 82 |
|
|
2024
Q2 | $1.02M | Buy |
8,249
+305
| +4% | +$39.3K | 0.26% | 77 |
|
|
2024
Q1 | $1.05M | Buy |
7,944
+345
| +5% | +$42.5K | 0.27% | 81 |
|
|
2023
Q4 | $828K | Buy |
7,599
+5
| +0.1% | +$519 | 0.22% | 84 |
|
|
2023
Q3 | $782K | Buy |
7,594
+5
| +0.1% | +$539 | 0.26% | 75 |
|
|
2023
Q2 | $876K | Buy |
7,589
+64
| +0.9% | +$7.27K | 0.29% | 63 |
|
|
2023
Q1 | $801K | Sell |
7,525
-50
| -0.7% | -$5.4K | 0.28% | 64 |
|
|
2022
Q4 | $840K | Buy |
7,575
+261
| +4% | +$26.7K | 0.29% | 60 |
|
|
2022
Q3 | $630K | Buy |
7,314
+5
| +0.1% | +$446 | 0.24% | 67 |
|
|
2022
Q2 | $666K | Buy |
7,309
+5
| +0.1% | +$443 | 0.25% | 64 |
|
|
2022
Q1 | $599K | Buy |
7,304
+7
| +0.1% | +$552 | 0.2% | 66 |
|
|
2021
Q4 | $559K | Buy |
7,297
+5
| +0.1% | +$398 | 0.18% | 69 |
|
|
2021
Q3 | $548K | Buy |
7,292
+6
| +0.1% | +$456 | 0.2% | 68 |
|
|
2021
Q2 | $567K | Sell |
7,286
-343
| -4% | -$25.5K | 0.21% | 65 |
|
|
2021
Q1 | $561K | Buy |
7,629
+5
| +0.1% | +$369 | 0.22% | 64 |
|
|
2020
Q4 | $595K | Buy |
7,624
+5
| +0.1% | +$382 | 0.25% | 54 |
|
|
2020
Q3 | $603K | Buy |
7,619
+3
| +0% | +$235 | 0.28% | 49 |
|
|
2020
Q2 | $562K | Buy |
7,616
+8
| +0.1% | +$602 | 0.28% | 52 |
|
|
2020
Q1 | $559K | Buy |
7,608
+4
| +0.1% | +$314 | 0.32% | 45 |
|
|
2019
Q4 | $660K | Buy |
7,604
+5
| +0.1% | +$411 | 0.32% | 50 |
|
|
2019
Q3 | $610K | Buy |
7,599
+4
| +0.1% | +$321 | 0.31% | 46 |
|
|
2019
Q2 | $608K | Buy |
7,595
+4
| +0.1% | +$306 | 0.32% | 44 |
|
|
2019
Q1 | $602K | Buy |
7,591
+6
| +0.1% | +$449 | 0.32% | 44 |
|
|
2018
Q4 | $553K | Buy |
7,585
+4,151
| +121% | +$293K | 0.34% | 44 |
|
|
2018
Q3 | $232K | Sell |
3,434
-58
| -2% | -$3.69K | 0.15% | 64 |
|
|
2018
Q2 | $202K | Buy |
+3,492
| New | +$197K | 0.14% | 63 |
|
Other funds holding MRK
VCM
VPM
Eldridge Investment Advisors's MRK Position: Q1 2026 in Review
Eldridge Investment Advisors reduced its Merck (MRK) stake by 14% in Q1 2026, selling an estimated $124K and leaving 6,793 shares worth $817K. The position accounts for 0.18% of the portfolio, ranked #78.
Eldridge Investment Advisors first reported a position in MRK in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.05M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Eldridge Investment Advisors held 6,793 shares of Merck worth $817K as of Q1 2026.
- Eldridge Investment Advisors sold 1,074 Merck shares in Q1 2026, an estimated $124K.
- Merck made up 0.18% of Eldridge Investment Advisors's portfolio in Q1 2026, its #78 holding.
- Eldridge Investment Advisors first reported a position in Merck in Q2 2018 and has held it in 32 quarters since.
- Eldridge Investment Advisors's Merck position peaked at $1.05M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Eldridge Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.